SRx Health Wins NYSE American Extension for Compliance Plan

The latest update is out from SRx Health Solutions ( (SRXH) ).

On January 6, 2026, SRx Health Solutions, Inc., listed on the NYSE American under the symbol SRXH, received notice that the exchange had accepted its plan to regain compliance with continued listing standards related to minimum stockholders’ equity. The exchange had previously notified the company on October 14, 2025, that it was out of compliance after reporting negative stockholders’ equity of $45.9 million as of June 30, 2025 and losses in three of its four most recent fiscal years ended December 31, 2024. With the NYSE American’s acceptance of its remediation plan, SRx Health Solutions’ listing will continue under an extension through July 14, 2026, during which the company must execute its plan to restore equity levels, provide quarterly progress updates to the exchange, and seek to regain full compliance, a move that stabilizes its immediate listing status but underscores ongoing financial pressures and execution risk for shareholders and other stakeholders.

The most recent analyst rating on (SRXH) stock is a Hold with a $0.19 price target. To see the full list of analyst forecasts on SRx Health Solutions stock, see the SRXH Stock Forecast page.

Spark’s Take on SRXH Stock

According to Spark, TipRanks’ AI Analyst, SRXH is a Neutral.

The score is driven primarily by weak financial performance (sharp revenue decline, very large losses, renewed cash burn, and high leverage), reinforced by bearish technicals (price below key moving averages and negative MACD). A very low P/E provides only limited support given the unstable fundamentals, while corporate events are offset by dilution and listing-compliance risks.

To see Spark’s full report on SRXH stock, click here.

More about SRx Health Solutions

Average Trading Volume: 12,710,963

Technical Sentiment Signal: Strong Sell

Current Market Cap: $14.06M

For a thorough assessment of SRXH stock, go to TipRanks’ Stock Analysis page.